Literature DB >> 18818210

Ziram causes dopaminergic cell damage by inhibiting E1 ligase of the proteasome.

Arthur P Chou1, Nigel Maidment, Rebecka Klintenberg, John E Casida, Sharon Li, Arthur G Fitzmaurice, Pierre-Olivier Fernagut, Farzad Mortazavi, Marie-Francoise Chesselet, Jeff M Bronstein.   

Abstract

The etiology of Parkinson disease (PD) is unclear but may involve environmental toxins such as pesticides leading to dysfunction of the ubiquitin proteasome system (UPS). Here, we measured the relative toxicity of ziram (a UPS inhibitor) and analogs to dopaminergic neurons and examined the mechanism of cell death. UPS (26 S) activity was measured in cell lines after exposure to ziram and related compounds. Dimethyl- and diethyldithiocarbamates including ziram were potent UPS inhibitors. Primary ventral mesencephalic cultures were exposed to ziram, and cell toxicity was assessed by staining for tyrosine hydroxylase (TH) and NeuN antigen. Ziram caused a preferential damage to TH+ neurons and elevated alpha-synuclein levels but did not increase aggregate formation. Mechanistically, ziram altered UPS function through interfering with the targeting of substrates by inhibiting ubiquitin E1 ligase. Sodium dimethyldithiocarbamate administered to mice for 2 weeks resulted in persistent motor deficits and a mild reduction in striatal TH staining but no nigral cell loss. These results demonstrate that ziram causes selective dopaminergic cell damage in vitro by inhibiting an important degradative pathway implicated in the etiology of PD. Chronic exposure to widely used dithiocarbamate fungicides may contribute to the development of PD, and elucidation of its mechanism would identify a new potential therapeutic target.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18818210      PMCID: PMC2596383          DOI: 10.1074/jbc.M802210200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  36 in total

1.  Systemic exposure to proteasome inhibitors causes a progressive model of Parkinson's disease.

Authors:  Kevin St P McNaught; Daniel P Perl; Anna-Liisa Brownell; C Warren Olanow
Journal:  Ann Neurol       Date:  2004-07       Impact factor: 10.422

2.  Proteasomal inhibition induced by manganese ethylene-bis-dithiocarbamate: relevance to Parkinson's disease.

Authors:  Y Zhou; F-S Shie; P Piccardo; T J Montine; J Zhang
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

Review 3.  Ubiquitin ligases and the immune response.

Authors:  Yun-Cai Liu
Journal:  Annu Rev Immunol       Date:  2004       Impact factor: 28.527

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Early and progressive sensorimotor anomalies in mice overexpressing wild-type human alpha-synuclein.

Authors:  Sheila M Fleming; Jonathan Salcedo; Pierre-Olivier Fernagut; Edward Rockenstein; Eliezer Masliah; Michael S Levine; Marie-Françoise Chesselet
Journal:  J Neurosci       Date:  2004-10-20       Impact factor: 6.167

6.  Environmental risk factors and Parkinson's disease: selective degeneration of nigral dopaminergic neurons caused by the herbicide paraquat.

Authors:  Alison L McCormack; Mona Thiruchelvam; Amy B Manning-Bog; Christine Thiffault; J William Langston; Deborah A Cory-Slechta; Donato A Di Monte
Journal:  Neurobiol Dis       Date:  2002-07       Impact factor: 5.996

7.  Effect of proteasome inhibitor on cultured mesencephalic dopaminergic neurons.

Authors:  Seiji Kikuchi; Kazuyoshi Shinpo; Sachiko Tsuji; Masayoshi Takeuchi; Shoichi Yamagishi; Zenji Makita; Masaaki Niino; Ichiro Yabe; Kunio Tashiro
Journal:  Brain Res       Date:  2003-02-28       Impact factor: 3.252

8.  Dysfunction of mitochondrial complex I and the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson's disease.

Authors:  Günter U Höglinger; Géraldine Carrard; Patrick P Michel; Fadia Medja; Anne Lombès; Merle Ruberg; Bertrand Friguet; Etienne C Hirsch
Journal:  J Neurochem       Date:  2003-09       Impact factor: 5.372

9.  Localization of alpha-, beta-, and gamma-synuclein during neuronal development and alterations associated with the neuronal response to axonal trauma.

Authors:  M C Quilty; W P Gai; D L Pountney; A K West; J C Vickers
Journal:  Exp Neurol       Date:  2003-07       Impact factor: 5.330

10.  Impairment of the ubiquitin-proteasome system causes dopaminergic cell death and inclusion body formation in ventral mesencephalic cultures.

Authors:  Kevin St P McNaught; Catherine Mytilineou; Ruth Jnobaptiste; Jocelyn Yabut; P Shashidharan; Peter Jennert; C Warren Olanow
Journal:  J Neurochem       Date:  2002-04       Impact factor: 5.372

View more
  30 in total

1.  The Drosophila vesicular monoamine transporter reduces pesticide-induced loss of dopaminergic neurons.

Authors:  Hakeem O Lawal; Hui-Yun Chang; Ashley N Terrell; Elizabeth S Brooks; Dianne Pulido; Anne F Simon; David E Krantz
Journal:  Neurobiol Dis       Date:  2010-05-26       Impact factor: 5.996

2.  Ubiquitination acutely regulates presynaptic neurotransmitter release in mammalian neurons.

Authors:  Gina V Rinetti; Felix E Schweizer
Journal:  J Neurosci       Date:  2010-03-03       Impact factor: 6.167

Review 3.  Agrochemicals, α-synuclein, and Parkinson's disease.

Authors:  Blanca A Silva; Leonid Breydo; Anthony L Fink; Vladimir N Uversky
Journal:  Mol Neurobiol       Date:  2012-08-30       Impact factor: 5.590

4.  Electrophilic adduction of ubiquitin activating enzyme E1 by N,N-diethyldithiocarbamate inhibits ubiquitin activation and is accompanied by striatal injury in the rat.

Authors:  Olga M Viquez; Samuel W Caito; W Hayes McDonald; David B Friedman; William M Valentine
Journal:  Chem Res Toxicol       Date:  2012-08-22       Impact factor: 3.739

5.  Bassoon and Piccolo maintain synapse integrity by regulating protein ubiquitination and degradation.

Authors:  Clarissa L Waites; Sergio A Leal-Ortiz; Nathan Okerlund; Hannah Dalke; Anna Fejtova; Wilko D Altrock; Eckart D Gundelfinger; Craig C Garner
Journal:  EMBO J       Date:  2013-02-12       Impact factor: 11.598

6.  A novel "molecular tweezer" inhibitor of α-synuclein neurotoxicity in vitro and in vivo.

Authors:  Shubhangi Prabhudesai; Sharmistha Sinha; Aida Attar; Aswani Kotagiri; Arthur G Fitzmaurice; Rajeswari Lakshmanan; Ravi Lakshmanan; Magdalena I Ivanova; Joseph A Loo; Frank-Gerrit Klärner; Thomas Schrader; Mark Stahl; Gal Bitan; Jeff M Bronstein
Journal:  Neurotherapeutics       Date:  2012-04       Impact factor: 7.620

7.  Ziram, a pesticide associated with increased risk for Parkinson's disease, differentially affects the presynaptic function of aminergic and glutamatergic nerve terminals at the Drosophila neuromuscular junction.

Authors:  Ciara A Martin; Katherine M Myers; Audrey Chen; Nathan T Martin; Angel Barajas; Felix E Schweizer; David E Krantz
Journal:  Exp Neurol       Date:  2015-10-09       Impact factor: 5.330

Review 8.  Of Pesticides and Men: a California Story of Genes and Environment in Parkinson's Disease.

Authors:  Beate R Ritz; Kimberly C Paul; Jeff M Bronstein
Journal:  Curr Environ Health Rep       Date:  2016-03

9.  Molecular tweezers for lysine and arginine - powerful inhibitors of pathologic protein aggregation.

Authors:  Thomas Schrader; Gal Bitan; Frank-Gerrit Klärner
Journal:  Chem Commun (Camb)       Date:  2016-08-22       Impact factor: 6.222

10.  Characterization of three human cell line models for high-throughput neuronal cytotoxicity screening.

Authors:  Zhi-Bin Tong; Helena Hogberg; David Kuo; Srilatha Sakamuru; Menghang Xia; Lena Smirnova; Thomas Hartung; David Gerhold
Journal:  J Appl Toxicol       Date:  2016-05-03       Impact factor: 3.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.